(ASMB) Assembly Biosciences - Performance -5.9% in 12m
Compare ASMB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-84.18%
#141 in Group
Rel. Strength
61.02%
#3102 in Universe
Total Return 12m
-5.92%
#44 in Group
Total Return 5y
-95.04%
#129 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ASMB (-5.9%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ASMB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASMB
Total Return (including Dividends) | ASMB | XBI | S&P 500 |
---|---|---|---|
1 Month | 41.83% | 2.02% | 2.87% |
3 Months | -10.40% | -15.44% | -6.42% |
12 Months | -5.92% | -14.02% | 9.87% |
5 Years | -95.04% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | ASMB | XBI | S&P 500 |
1 Month | 92.9% | 57% | 89.4% |
3 Months | -41.2% | -82.3% | -72% |
12 Months | -46.4% | -53.1% | 49.3% |
5 Years | -87.1% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #8 | 39.0% | 37.9% |
3 Month | #44 | 5.96% | -4.25% |
12 Month | #45 | 9.42% | -14.4% |
5 Years | #135 | -93.3% | -97.6% |
FAQs
Does ASMB Assembly Biosciences outperforms the market?
Yes,
over the last 12 months ASMB made -5.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months ASMB made -10.40%, while XBI made -15.44%.
Over the last 3 months ASMB made -10.40%, while XBI made -15.44%.
Performance Comparison ASMB vs Indeces and Sectors
ASMB vs. Indices ASMB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -13.3% | 39.0% | -20.3% | -15.8% |
US NASDAQ 100 | QQQ | -13.5% | 37.1% | -20.7% | -17.2% |
US Dow Jones Industrial 30 | DIA | -13.5% | 40.2% | -19.2% | -12.3% |
German DAX 40 | DAX | -15.4% | 22.6% | -45.8% | -31.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -13.9% | 35.6% | -19.5% | -11.6% |
Hongkong Hang Seng | HSI | -16.8% | 25.6% | -29.8% | -18.0% |
India NIFTY 50 | INDA | -10.9% | 39.6% | -22.2% | -8.25% |
Brasil Bovespa | EWZ | -15.3% | 30.3% | -29.5% | 0.56% |
ASMB vs. Sectors ASMB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -13.4% | 38.2% | -26.4% | -26.3% |
Consumer Discretionary | XLY | -14.2% | 38.3% | -18.1% | -20.0% |
Consumer Staples | XLP | -12.9% | 39.8% | -27.2% | -13.5% |
Energy | XLE | -14.2% | 41.8% | -14.3% | 3.84% |
Financial | XLF | -13.9% | 36.3% | -26.1% | -27.4% |
Health Care | XLV | -9.46% | 46.2% | -15.0% | - |
Industrial | XLI | -14.8% | 34.5% | -21.2% | -15.9% |
Materials | XLB | -13.2% | 37.1% | -16.2% | 0.11% |
Real Estate | XLRE | -12.9% | 35.7% | -22.6% | -19.4% |
Technology | XLK | -14.1% | 35.1% | -18.0% | -12.9% |
Utilities | XLU | -14.3% | 36.2% | -28.0% | -21.8% |
Aerospace & Defense | XAR | -13.8% | 32.5% | -29.6% | -31.1% |
Biotech | XBI | -5.17% | 39.8% | 0.80% | 8.10% |
Homebuilder | XHB | -12.8% | 38.8% | -6.63% | 3.83% |
Retail | XRT | -13.4% | 38.2% | -14.0% | -1.60% |